Search

A patent application has been submitted for a method of using 5 Alpha Dihydrotestosterone (5 Alpha-DHT) formulations to treat patients who are part of the LGBTQI+ community, including transgender and non-binary individuals. The application claims that these formulations can promote overall health, mental health, physical aesthetics, and hair growth in patients undergoing gender affirming hormone therapy or seeking to transition or modify their physical appearance. The method may also be used to treat Klinefelter syndrome. The patent application provides various embodiments and dosing regimens for administering 5 Alpha-DHT. [Extracted from the article]

A recent research article from Pirogov Russian National Research Medical University discusses the potential therapeutic applications of dehydroepiandrosterone (DHEA) and its metabolite, 5-androstenediol. DHEA is a precursor to all steroid hormones and has intracrine hormonal activity, making it beneficial for local treatment of various pathologies. Current clinical use of DHEA is limited to vaginal suppositories for vaginal atrophy and dyspareunia, but synthetic derivatives are being investigated for the treatment of various diseases. Additionally, 5-androstenediol shows promise as a treatment for acute radiation syndrome and as an immunostimulating agent during radiopharmaceutical therapy. The article explores the molecular targets and mechanisms of action of these steroids, as well as potential future applications. [Extracted from the article]

A recent study conducted at Peking University in Beijing, China, explored the effects of dehydroepiandrosterone (DHEA) on immune evasion in oral squamous cell carcinoma (OSCC). The researchers used a xenograft mouse model and immunohistochemistry to examine tumor-infiltrating lymphocytes (TILs). The study found that DHEA inhibited tumor growth, increased CD8+ cells, and decreased FOXP3+ cells in TILs. It also reduced the expression of B7-H4, a protein associated with immune escape in OSCC. The findings suggest that DHEA could be used to enhance the effectiveness of immunotherapy for OSCC. [Extracted from the article]

Researchers at Washington University have released new data on central nervous system agents, specifically the potentiation of the GABA A receptor by etiocholanolone and propofol. The study examined the relationship between receptor potentiation and background activity, finding that the free energy change contributed by the modulators is reduced at higher levels of control activity, which contradicts the coagonist model. The researchers discuss possible mechanisms underlying this discrepancy. This research has been peer-reviewed and published in the Biophysical Journal. [Extracted from the article]

A recent report from Aligarh Muslim University in Uttar Pradesh, India, discusses the synthesis and pharmacological properties of modified A- and D-ring Dehydroepiandrosterone (DHEA). DHEA is a naturally occurring steroid hormone that serves as a precursor for sex hormones. The research highlights the decline in DHEA levels with age and its link to hormone-deficiency symptoms. The review covers the synthetic routes and biological studies of modified A- and D-ring DHEA from 2015 to mid-2022. [Extracted from the article]

Researchers from Stellenbosch University have published a report on testosterone congeners, specifically focusing on the contribution of 11-oxy androgens to androgen excess and deficiency disorders. The study analyzed the circulating adrenal and gonadal steroid hormones in 70 healthy young men using advanced chromatography and mass spectrometry techniques. The results showed that testosterone was the most prominent androgen detected in all participants, while dihydrotestosterone was only detected in 25% of them. The presence of 11-oxy androgens was observed in most participants, significantly contributing to the androgen pool. The study suggests that analyzing both classical and 11-oxy androgens, along with dehydroepiandrosterone and 16-hydroxyprogesterone, may improve diagnostic accuracy in androgen excess or deficiency. [Extracted from the article]

A clinical trial, NCT06462482, is currently underway to examine the impact of testosterone administration on patients undergoing hip surgery. The study seeks to determine if providing patients with testosterone can prevent muscle loss and enhance outcomes following surgery. Participants will be randomly assigned to receive either testosterone or a placebo, and their progress will be monitored through questionnaires and testing. The trial is expected to conclude by August 2026. Additionally, this document provides details about a clinical trial that is not yet recruiting participants. The trial aims to investigate the effects of testosterone supplementation on male patients with femoroacetabular impingement (FAI) and labral tear. It plans to enroll 60 male patients aged 18 and above who have been clinically diagnosed with FAI and hypogonadism. Data collection is projected to be completed by August 31, 2026. The American Hip Institute is conducting the trial. [Extracted from the article]

A study conducted by the Chinese Academy of Sciences has found that sewage sludge in China contains androgen receptor (AR) disruptors, which can pose risks to human and ecological health. The researchers screened sewage sludge from 30 Chinese cities and identified 25 agonists and 33 antagonists that disrupt the AR. The study highlights the need for appropriate sludge management strategies to mitigate the potential toxicity of these disruptors. The research was supported by the National Natural Science Foundation of China and the National Key Research and Development Program of China. [Extracted from the article]

A study conducted by researchers at Jiangnan University in Wuxi, China, explores the enhancement of androstenedione production from phytosterols using multidirectional pathway engineering of Mycobacterium neoaurum LY-2. The researchers found that by knocking out the nonessential gene KasB and exploring key enzymes involved in androstenedione synthesis, they were able to increase production by 21.0%. Additionally, the heterologous expression of Vitreoscilla hemoglobin (VHb) in Mycobacterium neoaurum LY-2 further increased androstenedione concentration. The recombinant strain LY-2-Delta KasB-hsd4A-pcc-vgb produced an androstenedione concentration of 11.12 g/L when adding 20 g/L phytosterols. This research has been peer-reviewed. [Extracted from the article]

A recent study conducted by researchers at the University of Puerto Rico has found that the use of anabolic androgenic steroids (AAS), specifically nandrolone, in adolescent female rats has detrimental effects on their reproductive system. The study showed that nandrolone treatment led to increased body weight, decreased ovarian weight, and disrupted uterine morphology. Additionally, the drug altered the levels of hormones such as testosterone, estradiol, and progesterone in the rats. These findings highlight the need for further research on the long-term consequences of early nandrolone exposure on the female reproductive system and fertility. [Extracted from the article]

A recent study conducted by the Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy has found that dihydrotestosterone (DHT), a testosterone congener, can enhance the angiogenic and migratory potential of human endothelial progenitor cells (EPCs). The researchers discovered that DHT increased the proliferation, migration, and angiogenesis of EPCs, as well as their ability to integrate into cardiac tissue. These findings suggest that DHT could have potential therapeutic applications in cardiovascular regeneration and repair processes. Further research is needed to explore the full implications of these results. [Extracted from the article]

A report from the Ministry of Health of the Russian Federation discusses the potential use of the steroid hormone 5-androstenediol (5-AED) and its synthetic derivatives as radioprotective drugs. The research suggests that 5-AED is effective in protecting against ionizing radiation and is well-tolerated. It works by stimulating the synthesis of G-CSF, repairing DNA damage, and increasing the expression of inducible NO-synthase genes. The development of synthetic derivatives of 5-AED could enhance its bioavailability and create safe and effective radioprotective drugs. The research has been peer-reviewed and published in the Pharmaceutical Chemistry Journal. [Extracted from the article]

Researchers from Hebei University in China have discovered a series of novel peptide-dehydroepiandrosterone hybrids that effectively induce endoplasmic reticulum stress (ERS) and lead to apoptosis, showing promising anti-melanoma effects in vitro and in vivo. The lead compound, IId, demonstrated significant inhibition of tumor growth in mice and upregulated ERS markers, leading to cell apoptosis. The compound also showed effectiveness in inhibiting B16 cell migration and invasion. This research provides new insights into potential treatments for melanoma. [Extracted from the article]

A recent study conducted by researchers at the University of Zurich explores the effects of dihydrotestosterone (DHT) on endothelial progenitor cells (EPCs) and their role in cardiovascular regeneration. The study found that DHT had no cytotoxic effect on EPCs and actually enhanced their proliferation, viability, and ability to form capillary-like structures. DHT also promoted EPC migration and integration into cardiac tissue, suggesting its potential therapeutic applications in cardiovascular regeneration and repair processes. The findings highlight the positive impact of androgens on the cardiovascular system and offer insights into potential treatments for cardiovascular diseases. [Extracted from the article]

A study conducted by Uppsala University in Sweden has found that long-term use of anabolic androgenic steroids (AAS) can have severe adverse effects on physical, mental, and behavioral health. The study specifically focused on the effects of three different AAS compounds - nandrolone decanoate, testosterone decanoate, and trenbolone decanoate - on male rats. The results showed that nandrolone decanoate had the most significant impact, causing impaired memory function, changes in organ weights, and reduced body weight development. The study highlights the need for further research to fully understand the specific effects of different AAS compounds. [Extracted from the article]

A new study conducted at Chang Gung Memorial Hospital explores the association between anxiety and lung cancer. The researchers focused on the role of Dehydroepiandrosterone (DHEA), a neuroactive steroid that increases in response to stress. The study found that anxiety levels were significantly correlated with post-traumatic stress symptoms (PTSS) and fatigue. This association was particularly observed in patients with advanced cancer stages and those undergoing chemotherapy. The researchers suggest that further investigation is needed to determine if DHEA can serve as a potential biomarker for anxiety in lung cancer patients. [Extracted from the article]

A study conducted at Saveetha Engineering College in Tamil Nadu, India, explored the potential therapeutic effects of Withania somnifera (WS) root extract on the gonadal toxicity caused by Nandrolone decanoate (ND) therapy. ND is a commonly used steroid that can have adverse effects on reproductive functions. The study found that treatment with WS extract reversed the toxic effects of ND on the gonads in male rats, possibly due to its anti-inflammatory and antioxidant properties. The research suggests that WS extract may have potential as a protective agent against the reproductive damage caused by ND therapy. [Extracted from the article]

A study conducted by researchers at the Reproductive Medicine Center in Guangzhou, China, has found that intestinal microflora disturbance is a significant cause of polycystic ovary syndrome (PCOS). The study used a PCOS mouse model and various analytical techniques to investigate the mechanism of macrophage pyroptosis induced by intestinal microbiota disturbance in PCOS. The researchers discovered that macrophage pyroptosis, caused by intestinal flora disorder, can lead to PCOS through granulosa cell apoptosis and estrogen synthesis dysfunction. They suggest that macrophage pyroptotic inhibitors could be a potential therapeutic strategy for PCOS. [Extracted from the article]

A study conducted by researchers at Chungbuk National University in South Korea examined the effects of exercise intensity and duration on physiological changes in older adults participating in a forest therapy program. The program consisted of 20 sessions over 10 weeks, and participants were divided into different groups based on exercise intensity. The study found that moderate-intensity forest exercise led to a significant increase in immunoglobulin A levels, while dehydroepiandrosterone levels decreased in the daily activity group but significantly increased in the moderate-intensity forest exercise group. The researchers concluded that forest exercise has a beneficial effect on immunoglobulin A and dehydroepiandrosterone levels in older adults. [Extracted from the article]

The US Patent and Trademark Office has published a patent application titled "Compositions And Methods For Treatment Of Hidradenitis Suppurativa." The application, filed by inventors Ofer A. GOREN and John MCCOY and assigned to Suzhou Kintor Pharmaceuticals Inc., discusses the use of anti-androgen medications, specifically proxalutamide, for the treatment and prevention of hidradenitis suppurativa. The method involves administering an anti-androgen composition to the subject, which may include other medications or vaccines. Hidradenitis suppurativa is a chronic skin disease characterized by painful nodules and abscesses, and this patent application addresses the need for a new treatment option. The application provides detailed information about the method, composition, and related claims, as well as a kit for treating or preventing the condition. [Extracted from the article]

A recent study conducted by researchers at the First Affiliated Hospital of Anhui Medical University explores the relationship between insufficient sleep and prostatitis, a condition that affects men's physical and mental health. The study found that sleep deprivation (SD) led to a reduction in dihydrotestosterone and melatonin levels, which triggered the activation of the cGAS-STING pathway and the release of inflammatory cells into the prostatic stroma. The researchers also observed that mice with SD-induced prostatitis experienced relapses when subjected to SD again. This research provides valuable insights into the pathogenesis, therapeutic targets, and prevention strategies of prostatitis. [Extracted from the article]

A recent study conducted at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine in China explored the effects of berberine on glucolipid metabolism in rats with polycystic ovary syndrome (PCOS) and insulin resistance (IR). The researchers found that berberine treatment improved insulin sensitivity, reduced abnormal hormone levels, and normalized blood lipid levels in the PCOS-IR rats. Additionally, berberine protected the normal histological structures of the ovaries in these rats. These findings provide new insights into the therapeutic potential of berberine for patients with glucolipid metabolic disturbances associated with PCOS. [Extracted from the article]

A study conducted by researchers at the University of Leon in Spain examined the availability and information on the internet regarding the sale of three doping substances: oxandrolone, DHEA, and androstenedione. The study found that these substances are easily accessible online without a prescription, and the majority of websites selling them are not pharmacies. The researchers recommend that these products be sold through pharmacies to ensure quality and provide evidence-based information on their safe use, benefits, and risks. They also suggest that athletes consult health professionals for guidance on suitable supplements for their training and sports objectives. [Extracted from the article]

A recent study conducted by researchers at the University of Valencia in Spain explored the association between androgen deprivation therapy (ADT) and functional status and psychological alterations in patients with prostate cancer. The study found that high concentrations of androstenedione were significantly associated with frailty syndrome in both localized and metastatic prostate cancer patients receiving ADT. However, there were no significant relationships between the concentration of androgens in plasma and sleep quality, cognitive functions, or symptoms of depression. The researchers suggest that further investigation into the role of androstenedione as a biomarker for frailty syndrome in prostate cancer patients is needed. [Extracted from the article]

Researchers at Mohammed VI University Hospital Center in Oujda, Morocco have conducted a study comparing the efficacy of transdermal dihydrotestosterone and testosterone enanthate in treating idiopathic micropenis. The study involved 49 patients with idiopathic micropenis, with one group receiving transdermal dihydrotestosterone and the other group receiving testosterone enanthate. The results showed that transdermal dihydrotestosterone was superior to injectable exogenous testosterone in increasing penile size. No side effects were detected in either group. The study provides valuable insights into the treatment of idiopathic micropenis. [Extracted from the article]

Keywords: San Antonio; State:Texas; United States; North and Central America; 17-Ketosteroids; Androstenedione; Cytochromes; Drugs and Therapies; Gonadal Hormones; Hemeproteins; Proteins; Testosterone Congeners EN San Antonio State:Texas United States North and Central America 17-Ketosteroids Androstenedione Cytochromes Drugs and Therapies Gonadal Hormones Hemeproteins Proteins Testosterone Congeners 1941 1941 1 11/06/23 20231110 NES 231110 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Drugs and Therapies - Testosterone Congeners have been published. San Antonio, State:Texas, United States, North and Central America, 17-Ketosteroids, Androstenedione, Cytochromes, Drugs and Therapies, Gonadal Hormones, Hemeproteins, Proteins, Testosterone Congeners. [Extracted from the article]

According to the news reporters, the research concluded: "Additionally, we discovered that ADSC-Exos increased Ser9 phosphorylated glycogen synthase kinase-3 beta levels and facilitated nuclear translocation of beta-catenin, which may have been blocked by the specific Wnt/beta-catenin signaling pathway inhibitor dickkopf-related protein 1. Keywords: Guangzhou; People's Republic of China; Asia; Alopecia; Armadillo Domain Proteins; Bioengineering; Biomedical Engineering; Biomedicine; Biotechnology; Catenins; Cytoplasmic Structures; Dihydrotestosterone; Drugs and Therapies; Exosomes; Gonadal Hormones; Hair Diseases and Conditions; Health and Medicine; Hypotrichosis; Organelles; Proteins; Regenerative Medicine; Skin Diseases and Conditions; Skin and Connective Tissue Diseases and Conditions; Stem Cell Research; Testosterone Congeners; Transcription Factors; Transport Vesicles; beta Catenin EN Guangzhou People's Republic of China Asia Alopecia Armadillo Domain Proteins Bioengineering Biomedical Engineering Biomedicine Biotechnology Catenins Cytoplasmic Structures Dihydrotestosterone Drugs and Therapies Exosomes Gonadal Hormones Hair Diseases and Conditions Health and Medicine Hypotrichosis Organelles Proteins Regenerative Medicine Skin Diseases and Conditions Skin and Connective Tissue Diseases and Conditions Stem Cell Research Testosterone Congeners Transcription Factors Transport Vesicles beta Catenin 411 411 1 11/06/23 20231109 NES 231109 2023 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- New research on Biomedical Engineering - Regenerative Medicine is the subject of a report. [Extracted from the article]

ResultsAmong the novel derivatives, six were able to selectively protect PC12 cells through interaction with the TrkA receptor and five more to selectively protect TrkB-expressing cells via interaction with the TrkB receptor. 17-Ketosteroids, Chromaffin System, Dehydroepiandrosterone, Dehydroepiandrosterone Therapy, Chromaffin Cells, Drugs and Therapies, Gonadal Hormones, Testosterone Congeners, PC12 Cells Keywords: 17-Ketosteroids; Chromaffin Cells; Chromaffin System; Dehydroepiandrosterone; Dehydroepiandrosterone Therapy; Drugs and Therapies; Gonadal Hormones; PC12 Cells; Testosterone Congeners EN 17-Ketosteroids Chromaffin Cells Chromaffin System Dehydroepiandrosterone Dehydroepiandrosterone Therapy Drugs and Therapies Gonadal Hormones PC12 Cells Testosterone Congeners 1156 1156 1 10/16/23 20231020 NES 231020 2023 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in testosterone congeners. [Extracted from the article]

Keywords: Alopecia; Bioengineering; Biomedical Engineering; Biomedicine; Biotechnology; Cytoplasmic Structures; Dihydrotestosterone; Drugs and Therapies; Exosomes; Gonadal Hormones; Hair Diseases and Conditions; Health and Medicine; Hypotrichosis; Organelles; Regenerative Medicine; Skin Diseases and Conditions; Skin and Connective Tissue Diseases and Conditions; Stem Cell Research; Testosterone Congeners; Transport Vesicles EN Alopecia Bioengineering Biomedical Engineering Biomedicine Biotechnology Cytoplasmic Structures Dihydrotestosterone Drugs and Therapies Exosomes Gonadal Hormones Hair Diseases and Conditions Health and Medicine Hypotrichosis Organelles Regenerative Medicine Skin Diseases and Conditions Skin and Connective Tissue Diseases and Conditions Stem Cell Research Testosterone Congeners Transport Vesicles 390 390 1 10/16/23 20231016 NES 231016 2023 OCT 19 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- New research on regenerative medicine is the subject of a new report. This research using human hair follicle organs, in vitro dermal papilla cells, and in vivo animal models showed that ADSC-Exos not only encouraged healthy hair growth but also counteracted the inhibitory effects of DHT on hair growth.". [Extracted from the article]

17-Ketosteroids, Adnexal Diseases and Conditions, Androstenedione, Anterior Pituitary Hormones, Clinical Research, Clinical Trials and Studies, Corpus Luteum Hormones, Diet and Nutrition, Drugs and Therapies, Endocrine Research, Endocrine System Diseases and Conditions, Endocrine System Diseases and Conditions - Polycystic Ovary Syndrome, Enzymes and Coenzymes, Estradiol Congeners, Estrone, Estrone Therapy, Female Urogenital Diseases and Conditions, Glucose Metabolism Disorders, Gonadal Disorders, Gonadal Hormones, Health and Medicine, Hormones, Hyperinsulinism, Insulin Resistance, Nutritional and Metabolic Diseases and Conditions, Obstetrics, Ovarian Cysts, Ovarian Diseases and Conditions, Peptide Hormones, Peptide Proteins, Pharmaceuticals, Pituitary Gonadotropins, Polycystic Ovary Syndrome, Progesterone, Progesterone Congeners, Proinsulin, Prolactin, Reproductive Health, Syndromes, Testosterone Congeners, Therapy, Women's Health. [Extracted from the article]

For more information on this research see: Testosterone and dehydroepiandrosterone sulfate serum levels and anthropometric indices among patients with polycystic ovary syndrome taking metformin and cyproterone compound. Keywords: 17-Ketosteroids; Adnexal Diseases and Conditions; Adrenal Cortex Hormones; Antidiabetic Agents; Biguanides; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dehydroepiandrosterone Therapy; Diagnostics and Screening; Drugs and Therapies; Endocrine System Diseases and Conditions; Female Urogenital Diseases and Conditions; Gonadal Disorders; Gonadal Hormones; Gonadal Steroid Hormones; Health and Medicine; Hypoglycemic Agents; Metformin; Metformin Therapy; Non-Sulfonylureas; Ovarian Cysts; Ovarian Diseases and Conditions; Pharmaceuticals; Polycystic Ovary Syndrome; Syndromes; Testosterone Congeners; Waist Circumference; Women's Health EN 17-Ketosteroids Adnexal Diseases and Conditions Adrenal Cortex Hormones Antidiabetic Agents Biguanides Dehydroepiandrosterone Dehydroepiandrosterone Sulfate Dehydroepiandrosterone Therapy Diagnostics and Screening Drugs and Therapies Endocrine System Diseases and Conditions Female Urogenital Diseases and Conditions Gonadal Disorders Gonadal Hormones Gonadal Steroid Hormones Health and Medicine Hypoglycemic Agents Metformin Metformin Therapy Non-Sulfonylureas Ovarian Cysts Ovarian Diseases and Conditions Pharmaceuticals Polycystic Ovary Syndrome Syndromes Testosterone Congeners Waist Circumference Women's Health 2018 2018 1 07/31/23 20230801 NES 230801 2023 AUG 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in polycystic ovary syndrome. [Extracted from the article]

Keywords: Androgens; Bladder Cancer; Cancer; Cell Proliferation; Dihydrotestosterone; Drugs and Therapies; Gonadal Hormones; Health and Medicine; Oncology; Pharmaceuticals; Testosterone Congeners EN Androgens Bladder Cancer Cancer Cell Proliferation Dihydrotestosterone Drugs and Therapies Gonadal Hormones Health and Medicine Oncology Pharmaceuticals Testosterone Congeners 1319 1319 1 07/03/23 20230703 NES 230703 2023 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Researchers detail new data in bladder cancer. The news reporters obtained a quote from the research from Tianjin Medical University General Hospital: "In this study, dihydrotestosterone (DHT) significantly increased the proliferation and invasion of BLCA cells. [Extracted from the article]

17-Ketosteroids, Clinical Research, Clinical Trials and Studies, DHEA, Dehydroepiandrosterone, Dehydroepiandrosterone Therapy, Drugs and Therapies, Drugs and Therapies - Somatropin Therapy, Gonadal Hormones, Growth Hormones, Gynecology, Health and Medicine, Merck Serono, Pharmaceutical Companies, Pharmaceuticals, Somatropin Therapy, Steroids, Sugar Alcohols, Testosterone Congeners, Women's Health, Inositol The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders Undergoing ICSI: an Open Label Randomized Clinical Trial. [Extracted from the article]

Shenyang, People's Republic of China, Asia, 17-Ketosteroids, DHEA, Dehydroepiandrosterone, Dehydroepiandrosterone Therapy, Drugs and Therapies, Gonadal Hormones, Health and Medicine, Pharmaceuticals, Steroids, Testosterone Congeners Keywords: Shenyang; People's Republic of China; Asia; 17-Ketosteroids; DHEA; Dehydroepiandrosterone; Dehydroepiandrosterone Therapy; Drugs and Therapies; Gonadal Hormones; Health and Medicine; Pharmaceuticals; Steroids; Testosterone Congeners EN Shenyang People's Republic of China Asia 17-Ketosteroids DHEA Dehydroepiandrosterone Dehydroepiandrosterone Therapy Drugs and Therapies Gonadal Hormones Health and Medicine Pharmaceuticals Steroids Testosterone Congeners 2518 2518 1 04/03/23 20230407 NES 230407 2023 APR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on Drugs and Therapies - Testosterone Congeners are presented in a new report. [Extracted from the article]

Malatya, Turkey, Eurasia, 17-Ketosteroids, Adnexal Diseases and Conditions, Apoptosis, Biochemicals, Biochemistry, Cellular Physiology, Chemicals, Dehydroepiandrosterone, Dehydroepiandrosterone Therapy, Drugs and Therapies, Endocrine System Diseases and Conditions, Female Urogenital Diseases and Conditions, Gonadal Disorders, Gonadal Hormones, Health and Medicine, Inflammation, Ovarian Cysts, Ovarian Diseases and Conditions, Polycystic Ovary Syndrome, Syndromes, Testosterone Congeners, Women's Health Keywords: Malatya; Turkey; Eurasia; 17-Ketosteroids; Adnexal Diseases and Conditions; Apoptosis; Biochemicals; Biochemistry; Cellular Physiology; Chemicals; Dehydroepiandrosterone; Dehydroepiandrosterone Therapy; Drugs and Therapies; Endocrine System Diseases and Conditions; Female Urogenital Diseases and Conditions; Gonadal Disorders; Gonadal Hormones; Health and Medicine; Inflammation; Ovarian Cysts; Ovarian Diseases and Conditions; Polycystic Ovary Syndrome; Syndromes; Testosterone Congeners; Women's Health EN Malatya Turkey Eurasia 17-Ketosteroids Adnexal Diseases and Conditions Apoptosis Biochemicals Biochemistry Cellular Physiology Chemicals Dehydroepiandrosterone Dehydroepiandrosterone Therapy Drugs and Therapies Endocrine System Diseases and Conditions Female Urogenital Diseases and Conditions Gonadal Disorders Gonadal Hormones Health and Medicine Inflammation Ovarian Cysts Ovarian Diseases and Conditions Polycystic Ovary Syndrome Syndromes Testosterone Congeners Women's Health 702 702 1 03/23/23 20230324 NES 230324 2023 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on Endocrine System Diseases and Conditions - Polycystic Ovary Syndrome. [Extracted from the article]

17-Ketosteroids, DHEA, Dehydroepiandrosterone, Drugs and Therapies, Gonadal Hormones, Health and Medicine, Pharmaceuticals, Steroids, Testosterone Congeners, Dehydroepiandrosterone Therapy Keywords for this news article include: Shenyang Pharmaceutical University, Shenyang, People's Republic of China, Asia, DHEA, Pharmaceuticals, 17-Ketosteroids, Gonadal Hormones, Drugs and Therapies, Health and Medicine, Testosterone Congeners, Dehydroepiandrosterone Therapy. Keywords: 17-Ketosteroids; DHEA; Dehydroepiandrosterone; Dehydroepiandrosterone Therapy; Drugs and Therapies; Gonadal Hormones; Health and Medicine; Pharmaceuticals; Steroids; Testosterone Congeners EN 17-Ketosteroids DHEA Dehydroepiandrosterone Dehydroepiandrosterone Therapy Drugs and Therapies Gonadal Hormones Health and Medicine Pharmaceuticals Steroids Testosterone Congeners 2491 2491 1 03/23/23 20230317 NES 230317 2023 MAR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on testosterone congeners have been published. [Extracted from the article]

Keywords: 17-Ketosteroids; Androstenedione; Corpus Luteum Hormones; Drugs and Therapies; Engineering; Estradiol Congeners; Estradiol Therapy; Estrogens; Genetics; Genitalia; Germ Cells; Gonadal Hormones; Gynecology; Health and Medicine; Hormone Replacement Therapy; Hormones; Pharmaceuticals; Progesterone; Sex Hormones; Stem Cell Research; Technology; Testosterone Congeners; Vaginal Agents; Vaginal Preparations; Women's Health; Wyss Institute for Biologically Inspired Engineering at Harvard EN 17-Ketosteroids Androstenedione Corpus Luteum Hormones Drugs and Therapies Engineering Estradiol Congeners Estradiol Therapy Estrogens Genetics Genitalia Germ Cells Gonadal Hormones Gynecology Health and Medicine Hormone Replacement Therapy Hormones Pharmaceuticals Progesterone Sex Hormones Stem Cell Research Technology Testosterone Congeners Vaginal Agents Vaginal Preparations Women's Health Wyss Institute for Biologically Inspired Engineering at Harvard 2023 MAR 10 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Despite the fact that we all start out as an egg cell in one of our mother's ovaries, these human reproductive organs are surprisingly under-studied. A supportive somatic scaffold from stem cells The developing ovary contains both germ cells, which grow into egg cells, and somatic cells, which support the germ cells. The human germ cells did not live long enough to develop further into egg cells, but the human ovaroids started to form empty, follicle-like structures composed of the granulosa-like cells after about 16 days, despite the fact that there were no egg cells present. [Extracted from the article]

Egypt, Africa, Drugs and Therapies, Gonadal Hormones, Cairo, Health and Medicine, Nandrolone Decanoate Therapy, Pharmaceuticals, Testosterone Congeners, Nandrolone Keywords: Cairo; Egypt; Africa; Drugs and Therapies; Gonadal Hormones; Health and Medicine; Nandrolone; Nandrolone Decanoate Therapy; Pharmaceuticals; Testosterone Congeners EN Cairo Egypt Africa Drugs and Therapies Gonadal Hormones Health and Medicine Nandrolone Nandrolone Decanoate Therapy Pharmaceuticals Testosterone Congeners 1688 1688 1 03/23/23 20230305 NES 230305 2023 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Investigators discuss new findings in Drugs and Therapies - Nandrolone Decanoate Therapy. [Extracted from the article]

Cancer, Chemotherapy, Colon Cancer, Dihydrotestosterone, Drug Resistance, Drugs and Therapies, Gonadal Hormones, Health and Medicine, Oncology, Testosterone Congeners Keywords: Cancer; Chemotherapy; Colon Cancer; Dihydrotestosterone; Drug Resistance; Drugs and Therapies; Gonadal Hormones; Health and Medicine; Oncology; Testosterone Congeners EN Cancer Chemotherapy Colon Cancer Dihydrotestosterone Drug Resistance Drugs and Therapies Gonadal Hormones Health and Medicine Oncology Testosterone Congeners 1243 1243 1 03/24/23 20230228 NES 230228 2023 FEB 28 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on colon cancer. [Extracted from the article]